Ryeqo

relugolix; norethisterone acetate; estradiol hemihydrate · Gedeon Richter Plc.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Ryeqo, covering 2024-02-23 to 2026-08-20. Get the full timeline:

Most recent: EMA Authorised: Ryeqo (relugolix;norethisterone acetate;estradiol hemihydrate) — Gedeon Richter Plc.